血小板结合C4d(PC4d)在预测系统性红斑狼疮患者未来血栓事件风险中的作用
研究纳入418例系统性红斑狼疮患者,采用流式细胞术检测血小板结合C4d(PC4d)水平,并通过电子病历确认血栓事件。PC4d>13 MFI预测未来动脉血栓的HR为4.34,且与全部血栓事件相关(OR 2.45)。PC4d≤13 MFI对动脉血栓的阴性预测值为99%。
要点
- PC4d>13 MFI预测未来动脉血栓,HR 4.34(95%CI 1.03-18.3),P=0.046。
- PC4d>13 MFI与全部血栓事件相关,OR 2.45(95%CI 1.37-4.32),P=0.0016。
- PC4d≤13 MFI对动脉血栓阴性预测值99%(95%CI 97-100%)。
核心结论
- PC4d>13 MFI预测未来动脉血栓并与全部血栓事件相关。
- PC4d≤13 MFI的SLE患者在未来3年内不发生动脉血栓或任何血栓的概率高。
- PC4d水平可能有助于预测SLE患者未来血栓事件风险。
研究设计与样本
- 研究纳入418例系统性红斑狼疮患者,采用流式细胞术检测PC4d水平,血栓事件通过电子病历数据审核确认。
主要发现
- 在PC4d检测后3年内,15例受试者发生19次事件(13次动脉、6次静脉)。
- PC4d>13 MFI预测未来动脉血栓的HR为4.34(95%CI 1.03-18.3),P=0.046,诊断OR为4.30(95%CI 1.19-15.54)。
- PC4d≤13 MFI对动脉血栓的阴性预测值为99%(95%CI 97-100%)。
- PC4d>13 MFI预测全部血栓(动脉和静脉)未达统计学显著(诊断OR 2.50 [95%CI 0.88-7.06],P=0.08)。
- PC4d>13 MFI与全部血栓(检测前5年至检测后3年共70次历史及未来动静脉事件)相关,OR为2.45(95%CI 1.37-4.32,P=0.0016)。
关键数值与推荐
- PC4d预测未来动脉血栓的最优切点为13 MFI。
- PC4d≤13 MFI对动脉血栓阴性预测值99%(95%CI 97-100%)。
- PC4d≤13 MFI对未来全部血栓事件阴性预测值97%(95%CI 95-99%)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Platelet-bound complement activation product C4d (PC4d) levels correlate with history of thrombosis in patients with systemic lupus erythematosus (SLE). The present study evaluated whether PC4d levels could assess risk of future thrombosis events. METHODS: PC4d level was measured by flow cytometry. Thromboses were confirmed by electronic medical record data review. RESULTS: The study included 418 patients. Nineteen events (13 arterial and 6 venous) occurred in 15 subjects in the 3 years post-PC4d level measurement. PC4d levels above the optimum cutoff of 13 mean fluorescence intensity (MFI) predicted future arterial thrombosis with a hazard ratio of 4.34 (95% confidence interval [95% CI] 1.03-18.3) (P = 0.046) and a diagnostic odds ratio (OR) of 4.30 (95% CI 1.19-15.54). Negative predictive value of PC4d level of ≤13 MFI for arterial thrombosis was 99% (95% CI 97-100%). Although a PC4d level of >13 MFI did not reach statistical significance for prediction of total thrombosis (arterial and venous) (diagnostics OR 2.50 [95% CI 0.88-7.06]; P = 0.08), it was associated with all thrombosis (n = 70 historic and future arterial and venous events in the 5 years pre- to 3 years post-PC4d level measurement) with an OR of 2.45 (95% CI 1.37-4.32; P = 0.0016). In addition, the negative predictive value of PC4d level of ≤13 MFI for all future thrombosis events was 97% (95% CI 95-99%). CONCLUSIONS: A PC4d level of >13 MFI predicted future arterial thrombosis and was associated with all thrombosis. Patients with SLE presenting with a PC4d level of ≤13 MFI had high probability of not experiencing arterial or any thrombosis in the 3 years afterwards. Taken together, these findings indicate that PC4d levels may help predict the risk of future thrombosis events in SLE.
引用
- Gartshteyn Y, Conklin J, Petri MA, et al. Role of Platelet-Bound C4d (PC4d) in Predicting Risk of Future Thrombotic Events in Systemic Lupus Erythematosus. Arthritis Care Res (Hoboken). 2023. PMID: 36807703. doi:10.1002/acr.25107
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。